BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension

CompletedOBSERVATIONAL
Enrollment

109

Participants

Timeline

Start Date

May 2, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

February 28, 2021

Conditions
Pulmonary Arterial Hypertension
Interventions
DIAGNOSTIC_TEST

hepcidin levels and BMPR2 expression

Samples will be collected in the three groups. Hepcidin levels will be measured in serum using ELISA and BMPR2 expression will be assessed as previously described using real time-qPCR

Trial Locations (1)

69126

Centre for Pulmonary Hypertension at the Thoraxklinik, Heidelberg University Hospital, Heidelberg

All Listed Sponsors
collaborator

University Hospital Heidelberg

OTHER

collaborator

Hannover Medical School

OTHER

collaborator

University Hospital Carl Gustav Carus

OTHER

collaborator

University of Leipzig

OTHER

collaborator

University of Giessen

OTHER

lead

Heidelberg University

OTHER

NCT04086537 - BMPR2 Mutations and Iron Metabolism in Pulmonary Arterial Hypertension | Biotech Hunter | Biotech Hunter